Announced Tue, 7 Jul · 12:44 IST
Routine RTA compliance certificate for Q1 FY27 filed with exchanges
Compliance View source PDF
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹421.35
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.4-3.4-4.5-5.1-5.4-8.0-9.6———
Up moveDown movePending
AI summary
SMS Pharmaceuticals filed the quarterly certificate from its registrar Aarthi Consultants under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate confirms that shares received for dematerialization were processed within 15 days, physical certificates were mutilated and cancelled, and the depository's name was substituted as the registered owner. This is a standard procedural compliance filing required every quarter.
Likely market impact
No impact on shareholders. This is a routine regulatory housekeeping filing with no material information.